| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |